Get the Stockscreener App
2.39
3.91%
0.09
After Hours:
2.30
-0.09
-3.77%
Sintx Technologies Inc stock is traded at $2.39, with a volume of 65,276.
It is up +3.91% in the last 24 hours and down -10.15% over the past month.
SINTX Technologies Inc is an advance ceramics company that develops, manufactures, and commercializes silicon nitride biomaterials, composites, devices, and related technologies for medical and other high-value applications. It provides biomedical solutions for medical devices specializing in silicon nitride (Si3N4) for musculoskeletal and antipathogenic applications. It also manufactures silicon nitride parts for customers in the electrical, aerospace, and other industrial sectors. The company is a globalised leader in the research, development, and manufacturing of silicon nitride, and its products have been implanted in humans. The Company operates as one operating segment.
See More
Previous Close:
$2.30
Open:
$2.3275
24h Volume:
65,276
Relative Volume:
1.85
Market Cap:
$10.32M
Revenue:
$1.02M
Net Income/Loss:
$-10.36M
P/E Ratio:
-0.3838
EPS:
-6.2265
Net Cash Flow:
$-8.76M
1W Performance:
+5.52%
1M Performance:
-10.15%
6M Performance:
-25.55%
1Y Performance:
-14.95%
1-Day Range:
$2.305
$2.44
1-Week Range:
$2.1366
$2.44
52-Week Range:
$1.99
$6.78
Sintx Technologies Inc Stock (SINT) Company Profile
Name
Sintx Technologies Inc
Sector
Industry
Phone
801-839-3516
Address
1885 WEST 2100 STREET, SALT LAKE CITY, UT
Compare SINT vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SINT
Sintx Technologies Inc
|
2.39 | 9.93M | 1.02M | -10.36M | -8.76M | -6.2265 |
ABT
Abbott Laboratories
|
87.41 | 152.88B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
316.48 | 120.18B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
78.60 | 100.34B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
57.78 | 84.95B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.78 | 47.91B | 6.30B | 1.07B | 1.09B | 1.8406 |
Sintx Technologies Inc Stock (SINT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-13-26 | Initiated | H.C. Wainwright | Buy |
| Sep-12-19 | Initiated | Ascendiant Capital Markets | Buy |
Sintx Technologies Inc Stock (SINT) Latest News
SiNtx Technologies (SINT) Attempts Recovery, Faces Key Test at $2.47 ResistanceTrader Community Signals - Newser
SiNtx Technologies (SINT) Stock Today: Drops -1.52% — Critical Support Levels 2026-05-21Low Risk Entry Stocks - Newser
H.C. Wainwright reiterates Buy on SINTX Tech stock, $10 target - Investing.com
H.C. Wainwright reiterates Buy on SINTX Tech stock, $10 target By Investing.com - Investing.com Nigeria
SINT Reiterated by HC Wainwright & Co. -- Price Target Maintained at $10 - GuruFocus
What's Next for SiNtx Technologies (SINT) at $2.20? 2026-05-20Impulse Wave - Newser
SINTX Technologies to present silicon nitride biomaterials progress at LD Micro Invitational. - Pluang
SINTX Technologies to Present at the LD Micro Invitational XVI Conference - TMX Newsfile
Medical ceramics firm SINTX to discuss implant progress at LD Micro - Stock Titan
SINTX Technologies Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Sintx Technologies, Inc. 1Q 2026: Revenue $380K, Net income $(2,821K) — 10-Q Summary - TradingView
Sintx Technologies, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
SiNtx Technologies (SINT) Fell -5.62% — Is a Recovery Ahead? 2026-05-15Crowd Signals - Newser
SINTX Technologies (NASDAQ: SINT) Q1 2026 loss and going concern warning - Stock Titan
SiNtx Technologies (SINT) Q4 2025 Earnings Miss by Significant: Key TakeawaysProfessional Trade Ideas - Newser
SiNtx Technologies, Inc.Common Stock (NQ: SINT - FinancialContent
SINT SiNtx Technologies posts narrow Q4 2025 EPS miss, shares rally 15.87 percent on positive investor sentiment.Competitive Advantage - newser.com
SINT Price Today: SiNtx Technologies, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
SINT Technical Analysis & Stock Price Forecast - Intellectia AI
SINT Forecast, Price Target & Analyst Ratings | SINTX TECHNOLOGIES INC (NASDAQ:SINT) - ChartMill
SiNtx Technologies (SINT) Stock: Buy, Sell, Hold? (+0.37%) 2026-04-18Undervalued Stocks - Xã Thanh Hà
Robert Ryan Elmore Net Worth (2026) - GuruFocus
H.C. Wainwright Initiates Sintx Technologies(SINT.US) With Buy Rating, Announces Target Price $10 - 富途牛牛
Sintx Technologies (SINT) president granted 4,910 common shares as equity award - Stock Titan
SINT Initiates Coverage On SINTX Technologies -- Price Target An - GuruFocus
Published on: 2026-04-14 02:01:43 - baoquankhu1.vn
Trend Report: Can Sintx Technologies Inc disrupt its industryBond Market & Real-Time Volume Analysis Alerts - baoquankhu1.vn
Sintx Technologies (NASDAQ:SINT) Given New $12.00 Price Target at Ascendiant Capital Markets - Defense World
SINT Maintains 'Buy' Rating; Target Price Adjusted to $12 by Asc - GuruFocus
Setup Watch: Can Sintx Technologies Inc stock double in the next yearMarket Trend Summary & Free Growth Oriented Trading Recommendations - baoquankhu1.vn
Total debt per share of SINTX Technologies, Inc. – LSE:0A8S - TradingView — Track All Markets
EBITDA per share of SINTX Technologies, Inc. – LSE:0A8S - TradingView
SINT Stock Analysis: SiNtx Technologies Inc. MedTech Play at $2.52 After 1.18% Daily Dip - Newser
Insider Sell: Can Sintx Technologies Inc disrupt its industryDip Buying & Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Earnings Update: What is the PEG ratio of Sintx Technologies IncMarket Risk Report & Technical Confirmation Alerts - baoquankhu1.vn
SINTX Technologies Provides Corporate Business Update Highlighting First Human Implant, Strategic Transformation, and Commercial Execution - Orthopedics This Week
SINTX completes first human implant, names new president By Investing.com - Investing.com Australia
Sintx Technologies 2025 10‑K: Revenue $1.018M, Net Loss $10.364M - TradingView
SINTX completes first human implant, names new president - Investing.com
After its first human foot implant, SINTX shifts to 2026 rollout - Stock Titan
Sintx Technologies (SINT) to Release Quarterly Earnings on Monday - Defense World
SINTX Technologies: Advanced Silicon Nitride Ceramics for Biomedical, Technical, and Antipathogenic Applications 72 - Minichart
SINTX Technologies Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Sintx Technologies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - MarketScreener
SINTX Technologies (NASDAQ: SINT) outlines 2025 losses, cash and silicon nitride strategy - Stock Titan
SINTX completes first surgery with foot and ankle implant system By Investing.com - Investing.com India
SINTX Technologies Announces First-In-Human Surgery Using FDA-Cleared SINAPTIC® Foot & Ankle Implant - Orthopedics This Week
SINTX Technologies (SINT) Achieves Milestone with First Surgical Use of New System - GuruFocus
SINTX completes first surgery with foot and ankle implant system - Investing.com
Sintx Technologies announces first-in-human surgery using FDA-cleared Sinaptic® Foot & Ankle Implant - marketscreener.com
A new foot implant reaches its first patient after FDA clearance - Stock Titan
Sintx Technologies Inc Stock (SINT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.22%
1.41%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):